a Antidepressant drugs produce therapeutic actions and many of their side effects via blockade of the plasma membrane transporters for serotonin (SERT/SLC6A2), norepinephrine (NET/SLC6A1), and dopamine (DAT/SLC6A3). Many antidepressants block several of these transporters; some are more selective. Mouse gene knockouts of these transporters provide interesting models for possible effects of chronic antidepressant treatments. To examine the role of monoamine transporters in models of depression DAT, NET, and SERT knockout (KO) mice and wild-type littermates were studied in the forced swim test (FST), the tail suspension test, and for sucrose consumption. To dissociate general activity from potential antidepressant effects three types of behavior were assessed in the FST: immobility, climbing, and swimming. In confirmation of earlier reports, both DAT KO and NET KO mice exhibited less immobility than wild-type littermates whereas SERT KO mice did not. Effects of DAT deletion were not simply because of hyperactivity, as decreased immobility was observed in DAT + / -mice that were not hyperactive as well as in DAT -/ -mice that displayed profound hyperactivity. Climbing was increased, whereas swimming was almost eliminated in DAT -/ -mice, and a modest but similar effect was seen in NET KO mice, which showed a modest decrease in locomotor activity. Combined increases in climbing and decreases in immobility are characteristic of FST results in antidepressant animal models, whereas selective effects on swimming are associated with the effects of stimulant drugs. Therefore, an effect on climbing is thought to more specifically reflect antidepressant effects, as has been observed in several other proposed animal models of reduced depressive phenotypes. A similar profile was observed in the tail suspension test, where DAT, NET, and SERT knockouts were all found to reduce immobility, but much greater effects were observed in DAT KO mice. However, to further determine whether these effects of DAT KO in animal models of depression may be because of the confounding effects of hyperactivity, mice were also assessed in a sucrose consumption test. Sucrose consumption was increased in DAT KO mice consistent with reduced anhedonia, and inconsistent with competitive hyperactivity; no increases were observed in SERT KO or NET KO mice. In summary, the effects of DAT KO in animal models of depression are larger than those produced by NET or SERT KO, and unlikely to be simply the result of the confounding effects of locomotor hyperactivity; thus, these data support reevaluation of the role that DAT expression could play in depression and the potential antidepressant effects of DAT blockade.
Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions Antidepressant drugs produce therapeutic actions and many of their side effects via blockade of the plasma membrane transporters for serotonin (SERT/SLC6A2), norepinephrine (NET/SLC6A1), and dopamine (DAT/SLC6A3). Many antidepressants block several of these transporters; some are more selective. Mouse gene knockouts of these transporters provide interesting models for possible effects of chronic antidepressant treatments. To examine the role of monoamine transporters in models of depression DAT, NET, and SERT knockout (KO) mice and wild-type littermates were studied in the forced swim test (FST), the tail suspension test, and for sucrose consumption. To dissociate general activity from potential antidepressant effects three types of behavior were assessed in the FST: immobility, climbing, and swimming. In confirmation of earlier reports, both DAT KO and NET KO mice exhibited less immobility than wild-type littermates whereas SERT KO mice did not. Effects of DAT deletion were not simply because of hyperactivity, as decreased immobility was observed in DAT + / -mice that were not hyperactive as well as in DAT -/ -mice that displayed profound hyperactivity. Climbing was increased, whereas swimming was almost eliminated in DAT -/ -mice, and a modest but similar effect was seen in NET KO mice, which showed a modest decrease in locomotor activity. Combined increases in climbing and decreases in immobility are characteristic of FST results in antidepressant animal models, whereas selective effects on swimming are associated with the effects of stimulant drugs. Therefore, an effect on climbing is thought to more specifically reflect antidepressant effects, as has been observed in several other proposed animal models of reduced depressive phenotypes. A similar profile was observed in the tail suspension test, where DAT, NET, and SERT knockouts were all found to reduce immobility, but much greater effects were observed in DAT KO mice. However, to further determine whether these effects of DAT KO in animal models of depression may be because of the confounding effects of hyperactivity, mice were also assessed in a sucrose consumption test. Sucrose consumption was increased in DAT KO mice consistent with reduced anhedonia, and inconsistent with competitive hyperactivity; no increases were observed in SERT KO or NET KO mice. In summary, the effects of DAT KO in animal models of depression are larger than those produced by NET or SERT KO, and unlikely to be simply the result of the confounding effects of locomotor hyperactivity; thus, these data support reevaluation of the role that DAT expression could play in depression and the potential antidepressant effects of DAT blockade. 
Introduction
Inhibition of neurotransmitter reuptake by drugs acting at SERT, NET, and/or DAT can produce antidepressant effects (Skolnick et al., 2003; Lucki and O'Leary, 2004) , which, in part, has led to hypotheses that dysfunction of serotonin, norepinephrine, and/or dopamine systems might contribute to depression (Prange, 1964; Schildkraut, 1967; Akiskal and McKinney, 1973; van Praag, 1974; Willner, 1983a Willner, , b, c, 2000 Shelton, 2004; Dunlop and Nemeroff, 2007) . Most drugs that are clinically effective antidepressants in humans produce reduced immobility in the rodent forced swim test (FST) (Porsolt, 1979) . Modifications and extensions of the FST paradigm (Armario et al., 1988; Cervo and Samanin, 1991; Detke et al., 1995 Detke et al., , 1997 have sought to improve its specificity and predictive validity for human antidepressant efficacy (for review, see Cryan et al., 2005a) . These modified versions of the original test examine additional behavioral features and use slight modifications of the original apparatus that allow assessment of a broader behavioral repertoire. Such assessments may be especially important for studies of experimental manipulations that may alter both depressive behavior and general activity. In studies of Fawn Hooded rats that exhibit both hyperactivity (Hall et al., 1998b) and reduced immobility in forced swim testing (Hall et al., 1998a) , for example, the examination of several behavioral endpoints allowed dissociation of hyperactivity from antidepressant-like effects. Such considerations might thus be especially useful in studies of rodents with genetic manipulations that could alter both general levels of motor activity and depressive-like symptoms, such as dopamine transporter knockout (KO) mice (Giros et al., 1996; Sora et al., 1998) .
Monoamine transporter knockouts are potentially of interest in the study of antidepressant actions because they chronically elevate extracellular monoamine levels (Gainetdinov et al., 1998; Xu et al., 2000; Mathews et al., 2004; Shen et al., 2004) in a manner similar to antidepressant treatments (Abercrombie et al., 1988; Nomikos et al., 1990; Kreiss and Lucki, 1995) . Effects of SERT, NET, and DAT KO mice in antidepressant models may thus be of relevance in understanding the mechanisms that underlie antidepressant effects. Decreased immobility, a correlate of antidepressant activity, has been observed in NET KO mice (Xu et al., 2000) and DAT KO mice (Spielewoy et al., 2000) . No difference or increased immobility has been observed SERT KO mice depending on the background strain examined (Holmes et al., 2002) . All of these studies, however, have only examined immobility in the FST. Examination of other behaviors in this test (e.g. climbing and swimming) should help in clarifying the nature of these effects. In the case of DAT KO mice this is essential because DAT KO mice are hyperactive (Giros et al., 1996; Sora et al., 1998) . In an earlier study of DAT KO mice in the FST (Spielewoy et al., 2000) it was suggested that reductions in immobility were produced by increased 'swimming', but those authors did not in fact measure any other behavior in the test, nor differentiate between climbing and swimming. The nature of this behavior is rather important as it might reflect one of two possible effects, general activity or antidepressant activity.
As hyperactivity may be a confounding issue in the FST it is important to validate the findings of that model in other models of depression. Another model that has been extensively validated with a wide range of antidepressants is the tail suspension test (TST) (Cryan et al., 2005b) . SERT KO mice showed reduced immobility in the TST, which was dependent on the background strain against which the knockout was expressed (Holmes et al., 2002) , similar to observations in the FST. A similar profile has been observed in NET KO mice in the TST (DziedzickaWasylewska et al., 2006) , but this has not yet been assessed in DAT KO mice. Thus, to clarify and extend these data, we now report examination of behavior in DAT, SERT, and NET KO mice using both the FST and the TST under identical experimental conditions so that comparisons may be made between the relative magnitude of the effects of each of these monoamine transporter gene knockouts.
The TST, as well as the FST, might, however, be interpreted as being open to the confounding effects of hyperactivity. To further address this issue we examined another model, sucrose consumption, which should not be open to the same type of locomotor confound. The sucrose consumption model assesses a different aspect of depressive behavior, anhedonia, and was originally used to assess the depressive effects of chronic mild stress (Papp et al., 1991) , but has since been used to assess the effects of several other models of depression (El Yacoubi et al., 2003; Wintink et al., 2003; Shumake et al., 2005) .
Methods

Subjects
The KO mice used in these experiments were from the DAT-SERT (Sora et al., 2001 ) and NET-SERT (Hall et al., 2002) double KO lines described previously which were produced from crossing the original DAT (Sora et al., 1998) , SERT (Bengel et al., 1998) , and NET (Wang et al., 1999) single KO lines. The DAT mice used in these experiments from the DAT-SERT line were wild type (WT) for SERT, the SERT mice from the DAT-SERT line were WT for DAT and NET mice from the NET-SERT line were WT for SERT. For simplicity the second genotype, always + / + , is not included in the descriptions. These KO lines are therefore of a mixed C57BL/6J-129Sv background. Wild-type mice ( + / + ), heterozygote KO mice ( + / -), and homozygote KO mice ( -/ -) were genotyped by PCR, using two internal primers, one targeted at the knockout insertion sequence and the other targeted at the WT gene, and one external primer, which generated two products identifying the WT and KO genes. The DAT and SERT transgenic knockout insertion sequences contained a neomycin gene sequence (NEO), whereas the NET KO contained a green fluorescent protein gene insert. PCR using TaKaRa DNA polymerase (Takara Bio, Shiga, Japan) was performed on DNA that was eluted from tail biopsies after digestion overnight in Protease K. For DAT genotyping the external primer (5 0 AGT GTG TGC AGG GCA TGG TGT A 3 0 ) and the WT primer (5 0 TAG GCA CTG CTG ACG ATG ACT G 3 0 ) produced a 500-bp band, whereas the external primer and the NEO primer (5 0 CTC GTC GTG ACC CAT GGC GAT 3 0 ) produced a 600-bp band. For SERT genotyping the external primer (5 0 GCT CTC AGT CTT GTC TCC ATA AC 3 0 ) and the WT primer (5 0 TGC TGA CTG GAG TAC AGG CTA G 3 0 ) produced a 620-bp band, whereas the external primer and the NEO Animal models of depression Perona et al. 567
primer (5 0 CTC GTC GTG ACC CAT GGC GAT 3 0 ) produced a 800-bp band. For NET genotyping the external primer (5 0 GCT CTG TCC CTG TGC TTC ACG 3 0 ) and the WT primer (5 0 TGA GGC CTA AGC TGG AGC TCG 3 0 ) produced a 601-bp band, whereas the external primer and the green fluorescent protein primer (5 0 CGG TGA ACA GCT CCT CGC CC 3 0 ) produced a 470-bp band.
Forced swim test
This experiment used the FST (Porsolt et al., 1977) modified and validated in a manner similar to that described earlier for rats (Hall et al., 1998a) . On two successive days, DAT, SERT, and NET KO mice (n = 8-10/genotype) were placed in 3-l cylindrical beakers (diameter 19 cm) that were filled to a depth of 14 cm with 251C water. On the pretest day, mice were placed in the water for 15 min, towel-dried, placed under a warming lamp until completely dry, and then returned to their home cages. On the test day, the mice were placed into the water for 5 min and their behavior was recorded digitally. Their behavior was scored by observation of these recordings, blind to genotype. Durations of immobility, swimming, and climbing behaviors were measured using the TIMER behavioral scoring program (National Institutes of Health). 'Immobility' was defined as being stationary with only enough motion of the tail or forepaws to keep the head above water. The forepaws usually remained at the animal's sides. 'Swimming' was defined as active use of the forepaws with forward movement, in the center or along the sides of the cylinder, which did not involve lifting the paws above the surface of the water. The body was usually oriented parallel to the sides of the cylinder. 'Climbing' was defined as active pawing of the side of the cylinder, lifting the paws above the surface of the water. The body was oriented with the head toward the wall and the body oriented perpendicularly to the side of the cylinder. Inter-rater reliability estimates for these three measures were calculated by comparing the scores of two observers for 32 subjects. Reliability estimates for immobility (r = 0.88, P < 0.001), climbing (r = 0.86, P < 0.001), and swimming (r = 0.81, P < 0.001) were similar to the inter-rater reliability estimates obtained previously for rats (Hall et al., 1998a) .
As strain has been shown to affect responses to SERT and NET blockers in the FST (Lucki et al., 2001; David et al., 2003; Dulawa et al., 2004) , an additional experiment was performed to determine the sensitivity of WT mice from the DAT-SERT line to selective transporter blockers. The effects of pretreatment with saline (1 ml/100g IP), fluoxetine (30 mg/kg IP), desipramine (20 mg/kg IP), or GBR12909 (20 mg/kg IP), 30 min prior to the 5 min test on the second day were examined in WT mice (n = 8-9 per condition). In all other respects the experiment was identical to that described above.
Tail suspension test
In the TST DAT, SERT, and NET KO mice (n = 8-13/ genotype) were suspended by the tail from a horizontal metal rod (8 mm diameter) for 5 min. The duration of immobility was measured by an observer with a stopwatch.
Sucrose consumption test
In the sucrose consumption test DAT KO (n = 7-11 per genotype), SERT KO (n = 7-13 per genotype), and NET KO (n = 6-10 per genotype), were placed in a sucrose consumption chamber (DM-8 lick counter, Columbus Instruments, Columbus, OH) each day with access to water and sucrose. The number of licks for sucrose and water were monitored for 30 min. In a preliminary experiment the volume consumed as well as the number of licks was monitored. The correlation between licks and volume was found to be highly significant (r = 0.85, P < 0.01); thus only the number of licks is presented. To account for differing weight of the subjects the number of licks is presented as licks/100 g body weight. The subjects were tested over 9 days, 3 days at each concentration of sucrose (0.7, 7, and 34% sucrose).
Locomotor activity
Earlier studies found that DAT -/ -mice were profoundly hyperactive (Giros et al., 1996) , whereas locomotor activity was reduced in NET KO mice (Xu et al., 2000) . No basal differences in activity were found in SERT KO mice or in DAT + / -mice (Giros et al., 1996; Bengel et al., 1998; Xu et al., 2000) . Nonetheless, because differences in locomotor activity between genotypes might be thought to affect the paradigms described above, basal locomotion was assessed in DAT, SERT, and NET KO mice. For each gene knockout + / + , + / -and -/ -mice (n = 9-11 per genotype) were assessed for locomotor activity for 1 h under novel conditions. Total distance traveled was measured in Optovarimax activity monitors (Columbus Instruments) under dark, soundattenuated conditions using methods identical to our earlier publications with DAT KO, SERT KO, and DAT/ SERT KO mice (Sora et al., 1998 (Sora et al., , 2001 ).
Data analysis
The data were analyzed using analysis of variance (ANOVA) with the between-subjects factor of 'genotype', followed by Fisher's protected least significant difference (PLSD) for post-hoc comparisons where appropriate. For analysis of the sucrose consumption data, the additional within-subjects factors of 'sucrose' (sucrose vs. water) and 'concentration' (0.7, 7 and 34% sucrose) were included in the ANOVA. The data for the 3 days of testing at each concentration were averaged and the average values submitted to ANOVA. The effects of saline, fluoxetine, desipramine, and GBR12909 were compared by ANOVA followed by post-hoc comparison with Fisher's PLSD.
Results
Forced swim test
Deletion of the dopamine transporter gene profoundly affected FST behavior. The duration of immobility was decreased by DAT KO (Fig. 1a) so that DAT -/ -mice exhibited virtually no immobility [F(2,27) = 4.9, P < 0.02]. These results were significantly different from those obtained from littermate DAT + / + mice (P < 0.05). Immobility was also reduced in DAT -/ -mice. Immobility in these mice was intermediate between values for DAT +/+ and DAT -/-mice, although post-hoc comparisons did not reach statistical significance. The duration of swimming was also greatly reduced in DAT KO mice (Fig. 1b) [F(2,27) = 4.9, P < 0.02]. DAT -/ -mice exhibited virtually no swimming behavior. These differences achieved significance in comparison with DAT + / + (P < 0.05) and DAT + / -mice (P < 0.05). The duration of swimming was unaltered in DAT + / -mice compared with DAT + / + mice. DAT -/ -mice exhibited climbing behavior for almost the entire period of testing. Six of the 10 DAT -/ -subjects tested struggled to escape the cylinder for the entire session (Fig. 1c) . The duration of climbing was greatly increased in DAT KO mice [F(2,27) = 12.7, P < 0.001]. In this case, as for immobility, DAT + / -mice exhibited behavior that was intermediate between DAT + / + and DAT -/ -mice. The duration of climbing was significantly greater in DAT -/ -mice than in either DAT + / + or DAT + / -mice (P < 0.05). DAT + / -mice also exhibited significantly more climbing than WT DAT + / + mice (P < 0.05).
Deletion of the NET gene also reduced the duration of immobility in the FST [ Fig. 1a ; F(2,27) = 4.9, P < 0.02]. NET -/ -mice exhibited substantially reduced immobility when compared with NET + / + mice (P < 0.05). NET + / -mice did not differ significantly from WT mice. The duration of swimming was unaffected by NET KO [ Fig. 1b; F(2,24) Deletion of the SERT gene had no effect on any FST behavior. In WT mice a significant difference was observed between drug treatment groups for immobility [ Table 1 ; F(3,28) = 10.2, P < 0.001] and swimming followed by [ Table 1 ; F(3,28) = 5.4, P < 0.005], but not for climbing [ Table 1 ; F(3,28) = 1.4, NS]. Desipramine significantly reduced immobility (P < 0.05 vs. saline, Fisher's PLSD), and increased swimming (P < 0.05 vs. saline, Fisher's PLSD). Desipramine treatment also increased climbing but this difference was not statistically significant. In contrast, neither of the other two drugs, fluoxetine or GBR 12909, had any statistically significant effects, although a trend for GBR 12909 to decrease immobility and to increase climbing was observed.
Tail suspension test
Deletion of all three monoamine transporter genes decreased immobility in the TST (Fig. 2) : DAT The duration of immobility, swimming, and climbing in WT mice treated with saline, fluoxetine, desipramine, or GBR 12909 expressed as mean ± the standard error of mean. WT, wild type.
[F(2,34) = 6.5, P < 0.01], SERT [F(2,31) = 3.5, P < 0.05], and NET [F(2,23) = 3.9, P < 0.05]. In SERT KO mice, however, only homozygous mice exhibited a significant reduction in immobility (P < 0.05 Fisher's PLSD), whereas in DAT and NET KO mice both heterozygous and homozygous KO mice had reduced immobility compared with WT mice. The magnitude of the difference between + / + and -/ -mice differed between the knockout strains; the magnitude of the effect of a homozygous knockout was 74% in DAT KO mice, but only 51% in SERT KO and NET KO mice.
Sucrose consumption test
Deletion of the DAT gene increased sucrose consumption at all of the concentrations tested (Fig. 3a ). An overall preference for sucrose over water was observed for all subjects [sucrose: F(1,23) = 16.9, P < 0.001]. DAT -/ -mice had greater fluid consumption overall [genotype: F(2,23) = 6.2, P < 0.01], which was the result of greater consumption of sucrose, but not water at all concentrations tested [genotype Âsucrose: F(2,23) = 6.4, P < 0.01], especially at higher concentrations [genotype Âsucrose Â concentration: F(4,46) = 2.8, P < 0.05]. DAT + / -mice were not different from WT mice.
Sucrose consumption was not affected by SERT KO (Fig. 3b) or NET KO (Fig. 3c) . Although SERT KO mice showed a trend toward a reduction in sucrose consumption at the middle concentration, neither the main effect of genotype nor the interaction terms were significantly different in the ANOVA.
Locomotor activity
DAT -/ -mice were profoundly hyperactive [ Table 2 ; genotype: F(2,27) = 14.4, P < 0.001, P < 0.05 Fisher's PLSD], but there was no difference in activity between DAT + / -and DAT + / + mice. No significant differences in baseline activity were observed in NET KO or SERT KO mice, although both had strong trends toward reduced locomotion [ Table 2 ; NET: F(2,26) = 3.2, P = 0.06; SERT: F(2,27) = 3.1, P = 0.06].
Discussion
In this study, deletion of the DAT gene produced changes in behavior in three behavioral tests sensitive to antidepressant drugs. These effects were quite profound.
In the FST and TST, homozygous DAT KO mice spent nearly the entire duration of the test struggling to escape whereas sucrose consumption was greatly enhanced, consistent with increased rewarding effects (e.g. reduced anhedonia). Contrary to what might be supposed, based on naive preconceptions of the relative importance of each of these neurotransmitter systems in depression and the mechanisms of the majority of commonly used antidepressant compounds, although similar effects were observed in NET KO mice in both the FST and TST and in SERT KO mice in the TST, these effects were less pronounced than those observed in DAT KO mice. Such a comparison must, however, be considered in light of potential interactions with genetic background, as discussed below, but suggests at the very least that under some circumstances DAT manipulations can have greater effects on antidepressant-like phenotypes than previously appreciated.
DAT knockout almost completely eliminated immobility in the FST, consistent with an earlier finding (Spielewoy et al., 2000) . That report suggested that increased immobility was associated with increased swimming, but those authors did not actually measure any other behavior; in particular, there was no attempt to dissociate general activity (swimming) from specific activity aimed at escaping from the cylinder (climbing). In this experiment both immobility and swimming behavior were almost completely eliminated in DAT KO mice, replaced with persistent and almost continuous climbing (e.g. escape attempts). As DAT KO mice are hyperactive (Giros et al., 1996; Sora et al., 1998) , it might be supposed that differences in behavior in the FST between DAT + / + and DAT -/ -mice merely reflects this hyperactivity; indeed, this was the conclusion of the study mentioned earlier (Spielewoy et al., 2000) . Those authors interpreted the persistent attempts to escape of DAT KO mice in the FST as 'inappropriate' as opposed to the 'adaptive' strategy of immobility, in accordance with one interpretation of the paradigm (Borsini et al., 1986) . This interpretation is not generally accepted [see discussion of this subject in the review by Cryan et al. (2005a) ]. To some extent the use of a single-exposure forced swim paradigm in the Spielewoy et al. (2000) study, compared with a two exposure-forced swim paradigm in this study might lead to different interpretations of the results, the former relating more to acute stress, and the latter to 'behavioral despair'. Of course, the type of paradigm used in this study should be more related to antidepressant actions, which was one of the conclusions of the review mentioned earlier (Cryan et al., 2005a) .
Returning to the issue of hyperactivity, several lines of evidence weigh against such a simple explanation of the effects of DAT KO in the FST. Reduced immobility and increased climbing were observed in both homozygous and heterozygous DAT KO mice, yet heterozygous DAT KO mice are not hyperactive (Table 2) . Decreased immobility, although to a lesser extent, was also observed in NET KO mice, which are also not hyperactive (Table 2 ). In addition, decreased immobility in DAT KO mice was also observed in the TST, as was reduced immobility in both SERT KO and NET KO mice, consistent with earlier reports (Holmes et al., 2002; Dziedzicka-Wasylewska et al., 2006) , and hyperactivity was not observed in either of those knockout strains.
In any case, the description of DAT KO mice as hyperactive is probably not an accurate depiction of their behavior. This is based upon the placement of DAT KO mice in a novel environment in which exploratory activity would be the dominant initial response tendency. More accurately, DAT KO, like amphetamine treatment (Evenden and Robbins, 1983) , may increase the dominant response tendency. According to this view, escape behavior in TST and FST would be enhanced, and the present results would not be the result of hyperactivity per se. Behavior in a sucrose consumption test would not be confounded by locomotor hyperactivity in the same way as the other tests; indeed, pronounced locomotor hyperactivity should reduce sucrose consumption by producing a competing behavior. In contrast, DAT KO mice had increased consumption of sucrose when compared with WT mice. Increased sucrose consumption, particularly at low concentrations (e.g. 0.7% as in Fig. 3 ), has generally been taken to indicate differences in the hedonic properties of sucrose (Papp et al., 1991; El Yacoubi et al., 2003; Wintink et al., 2003; Shumake et al., 2005) . This additional evidence further indicates that the effects of DAT KO in the FST and the TST are probably not the result of the confounding effects of hyperactivity. No differences were found in sucrose consumption in SERTor NET KO mice, consistent with the lack of effect of SERT KO in the FST, and somewhat reduced effects of NET KO in both tests.
The meaning of the relative lack of effect of NET KO and SERT KO in the present experiments must be interpreted with caution, however, as substantial strain differences have been reported in the response to antidepressants in both FST and TST Gershenfeld, 2001, 2003; David et al., 2003 ; Ripoll et al., Locomotor activity in + / + , + / -, and -/ -genotypes of DAT, SERT, and NET KO mice. The data are expressed as the mean ± the standard error of mean. a Significant difference from + / + mice, Fisher's protected least significant difference.
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2003; Dulawa et al., 2004; Lucki and O'Leary, 2004; Crowley et al., 2005) . In particular, both C57BL/6 and 129Sv mice do not exhibit antidepressant-like effects in response to fluoxetine in the FST (Lucki et al., 2001; Dulawa et al., 2004) , although both strains seem to be responsive to a wide range of SERT, NET, and DAT blockers in the TST (Ripoll et al., 2003; Crowley et al., 2005) . In an interesting parallel to the present results, one study found that C57BL/6 mice were unresponsive to NET or SERT blockers in the FST, but did respond to GBR 12909 . In the current experiments, mixed C57BL/6-129Sv background WT mice did respond to desipramine in the FST, but not fluoxetine, consistent with findings in C57BL/6 mice (Lucki et al., 2001) , so that the effects of SERT KO in the present experiments should be treated with particular caution.
Comparison of pharmacological antagonism of transporters and constituitive gene knockouts should, however, be treated with caution in any case. Results of tests performed on adult KO mice need to be potentially interpreted in light of the effects of absence of the gene during development as well as at the time of testing. In DAT KO mice, in particular, it might be supposed that differences in depressive phenotypes may largely reflect developmental consequences of the deletion. However, there is substantial evidence of the role of dopamine in depression and in depressive phenotypes in animal models of depression (Randrup et al., 1975; Willner, 1983a Willner, ,b,c, 2000 Dunlop and Nemeroff, 2007) , much of it involving acute alterations in dopamine function. In humans the relatively selective DAT blocker, bupropion, and its metabolites, produce clinically effective antidepressant actions (Ascher et al., 1995; Jefferson et al., 2005; Volkow et al., 2005) . These findings are supported by numerous studies in animal models. Dopamine is also involved in anhedonia in the sucrose consumption model (Papp et al., 1991) , and in the FST dopamine agonists and selective dopamine reuptake blockers have antidepressant-like effects (Cooper et al., 1980; Vaugeois et al., 1996; Hemby et al., 1997; Damaj et al., 2004; Siuciak and Fujiwara, 2004; Basso et al., 2005) . In addition to reduced immobility, GBR 12909 selectively increased climbing behavior, but not swimming in the FST (Hemby et al., 1997) . Dopamine agonists also enhance the antidepressant-like effects of selective serotonin reuptake inhibitors (Renard et al., 2001) . The effects of DAT blockers are not the result of generally enhanced activity, as the effects of bupropion in the FST occur at doses that do not affect spontaneous locomotion (Cooper et al., 1980; David et al., 2003) . was observed in this study. The present data are also consistent with some earlier results using SERT KO mice, which were reported to have decreased immobility in the TST, but increased immobility in the FST when bred onto a 129S6 background, but did not display any differences in these tests when bred onto a C57BL/6J background (Holmes et al., 2002) . It is interesting to note that in the TST, the mixed background strain from this study had reduced immobility in the TST, similar to SERT KO mice on a 129S6 background in the Holmes et al. (2002) study, whereas no effect was observed in the FST, similar to C57BL/6J congenic mice in that study. This suggests somewhat different underlying genetic substrates for the TST and FST, consistent with some of the pharmacological findings in inbred strains discussed above.
In the FST antidepressants that act primarily at the serotonin transporter have been reported to increase swimming, whereas those that act primarily at the norepinephrine transporter have been reported to increase climbing (Detke et al., 1995 (Detke et al., , 1997 Detke and Lucki, 1996; Page et al., 1999; Cryan et al., 2002 Cryan et al., , 2003 . This was not found in desipramine-treated WT mice in this experiment. Nonetheless, it seems that changes in either type of active behavior and concomitant reductions in immobility may be associated with antidepressant-like effects. However, several models of depression, including those produced by withdrawal from amphetamine, ovarian hormone treatments that simulate pregnancy, and estrogen deficiencies caused by aromatase knockout, increase FST immobility and decrease climbing without affecting swimming (Galea et al., 2001; Cryan et al., 2003; Dalla et al., 2004) . These depressive-like effects are mirrored by the opposite, antidepressant-like effects of amphetamine administration, pregnancy, or estradiol: decreased immobility and increased climbing, in the absence of substantial changes in swimming (Galea et al., 2001; Molina-Hernandez and Tellez-Alcantara, 2001; Cryan et al., 2003) . The pattern of antidepressant effects in these models is very similar to that observed in DAT KO mice, whereas the effects in models of depression are opposite to those observed in DAT KO mice.
The current results thus support a prominent role for DAT, and dopamine, in the mediation of antidepressantlike behavior, as assessed by the models used here. The striking magnitude of the effects of DAT KO, particularly in comparison with the more modest consequences or lack of consequences of NET or SERT KO, each support reevaluation of the clinically proven effects of DAT blockade on depression, and the role of the DAT gene or differences in DAT gene expression in individual differences in depression and responses to effective antidepressant treatments. The pronounced effects of background strain in both pharmacological and transgenic studies indicate that these very strong DAT effects may be limited to certain genetic backgrounds, but the data suggest that, under these circumstances, DAT may have more importance than SERT or NET. It remains to be seen whether such profound and prominent effects may be observed for NET or SERT gene knockout when it is expressed on other genetic backgrounds in which SERT and NET blockers have more pronounced effects. Taken together, these data suggest that manipulations of DAT, SERT, and NET genes are highly dependent on genetic background and raise the possibility that this may influence both baseline depressive behavior and response to antidepressants acting selectively at each of these transporters.
